Tagged with China

China MSD China’s Michel Vounastos gives his initial impressions of the opportunities and challenges inherent in the Chinese healthcare market, and highlights how MSD’s offerings are able to address specific gaps in the country. You just arrived in China in February. The country managers we’ve met have all been here for…

Alliance of Bio-Box Outsourcing China Please introduce to our readers the general situation and driving force behind the creation of the Beijing Pharma and Biotech Center and its core mandate? Established in 1996, BPBC is an affiliated agency of the Beijing Municipal Science and Technology Commission and serves as a professional service organization for the…

Hooker Cockram - China Hooker Cockram is a well established company with an, impressive and rich history. Could you give us some background on both your operations in Australia and your operations in China since 1993? Hooker Cockram is Australia’s oldest construction company, in existence for 149 years. For 125 years, the firm was…

Covance China You have had significant experience at GSK and Pfizer, and also at Frontage Labs doing more entrepreneurial work. What ultimately brought you to Covance? I worked in Big Pharma for about 14 years, which was the longest phase of my career. I have a strong passion for drug development –…

China Medicinal Biotech Association (CMBA) Could you please give us a brief introduction on CMBA? First and most obviously for new arrivals to our office, since 2011 we have changed locations, making it more convenient for companies to come here and benefit from the opportunities we can provide our members. CMBA’s membership now totals 205…

Novo Nordisk China We found a Capital Markets Day presentation from Novo Nordisk that talked about the “rule of halves” – that of all people with diabetes, 50% of diagnosed, and of those 50% have access to care, and of those 50% get decent care, and finally 50% of those reach their targets.…

China In the last decade the medical device sector has undergone a lot of change; China has become a net importer to a net exporter of these devices. What is your outlook as to how this happened so quickly and what the key factors that revolutionized the industry? During the first…

Array Liam Condon, Managing Director of Bayer Healthcare China discusses the  government’s recent announcements regarding its much-anticipated healthcare reform plan, the future benefits of investing in rural healthcare, and the company’s main ambitions in China over the next five years.         It has been a rollercoaster four years…

HUYA Bioscience International - China Your business is very much relationship based here in China. You’ve now established a number of relationships with institutes, universities and companies, but I can imagine that breaking into this market and building those relationships was a challenge. How did you grow this business in the early days? The early…